loading
Precedente Chiudi:
$2.38
Aprire:
$2.38
Volume 24 ore:
30,171
Relative Volume:
0.47
Capitalizzazione di mercato:
$2.05M
Reddito:
-
Utile/perdita netta:
$-11.66M
Rapporto P/E:
-0.2452
EPS:
-10.156
Flusso di cassa netto:
$-11.09M
1 W Prestazione:
+11.66%
1M Prestazione:
-21.70%
6M Prestazione:
-63.59%
1 anno Prestazione:
-71.72%
Intervallo 1D:
Value
$2.3601
$2.5506
Intervallo di 1 settimana:
Value
$2.1678
$2.66
Portata 52W:
Value
$2.1678
$18.81

Phio Pharmaceuticals Corp Stock (PHIO) Company Profile

Name
Nome
Phio Pharmaceuticals Corp
Name
Telefono
(508) 767-3861
Name
Indirizzo
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
Name
Dipendente
9
Name
Cinguettio
@phio_pharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PHIO's Discussions on Twitter

Confronta PHIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
PHIO 2.49 2.05M 0 -11.66M -11.09M -10.16
VRTX 449.99 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.25 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 593.04 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.84 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.23 24.89B 3.30B -501.07M 1.03B 11.54

Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-08-05 Iniziato H.C. Wainwright Buy

Phio Pharmaceuticals Corp Borsa (PHIO) Ultime notizie

pulisher
Nov 19, 2024

Phio Pharmaceuticals Announces Completion of Enrollment in Second - The Kingston Whig-Standard

Nov 19, 2024
pulisher
Nov 19, 2024

Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study - Newsfile

Nov 19, 2024
pulisher
Nov 15, 2024

Phio Pharmaceuticals Corp. (PHIO) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - Alberta Daily Herald Tribune

Nov 14, 2024
pulisher
Nov 14, 2024

Phio Pharmaceuticals Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 13, 2024

PHIO stock touches 52-week low at $2.38 amid market challenges - Investing.com

Nov 13, 2024
pulisher
Nov 08, 2024

Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail

Nov 08, 2024
pulisher
Nov 07, 2024

PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - Newsfile

Nov 07, 2024
pulisher
Nov 01, 2024

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Quantisnow

Nov 01, 2024
pulisher
Oct 24, 2024

Phio Pharmaceuticals Announces Upcoming Presentation at the 39th - Shoreline Beacon

Oct 24, 2024
pulisher
Oct 23, 2024

Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile

Oct 23, 2024
pulisher
Oct 23, 2024

Financial Analysis: Dianthus Therapeutics (NASDAQ:DNTH) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Oct 23, 2024
pulisher
Oct 18, 2024

Nasdaq Financial 100 Index (IXF) QuotePress Release - The Globe and Mail

Oct 18, 2024
pulisher
Oct 18, 2024

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - StockTitan

Oct 18, 2024
pulisher
Oct 16, 2024

Phio Pharmaceuticals presents novel cancer therapy data - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Phio Pharmaceuticals presents novel cancer therapy data By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference - Newsfile

Oct 16, 2024
pulisher
Oct 08, 2024

Understanding the Risks of Investing in Phio Pharmaceuticals Corp (PHIO) - Knox Daily

Oct 08, 2024
pulisher
Oct 07, 2024

Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA - MSN

Oct 07, 2024
pulisher
Oct 07, 2024

Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells - Newsfile

Oct 07, 2024
pulisher
Oct 05, 2024

Phio Pharmaceuticals (NASDAQ:PHIO) Shares Down 2.5% – Time to Sell? - Defense World

Oct 05, 2024
pulisher
Oct 01, 2024

Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Nu Holdings Ltd Cl A (NU-N) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 25, 2024

This trade activity should not be overlooked: Hyliion Holdings Corporation (HYLN) - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

INTASYL Technology and Compounds to be Focus of Presentation at 20th - North Bay Nugget

Sep 25, 2024
pulisher
Sep 25, 2024

INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society - Newsfile

Sep 25, 2024
pulisher
Sep 25, 2024

HITE Hedge Asset Management LLC Sells 12,931 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Sep 25, 2024
pulisher
Sep 24, 2024

Hyliion Holdings Corporation (HYLN) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Sep 24, 2024
pulisher
Sep 23, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Financial Metrics Unveiled: P3 Health Partners Inc (PIII)’s Key Ratios in the Spotlight - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Does Hyliion Holdings Corporation (NYSE: HYLN) Still Need To Convince Analysts? - Stocks Register

Sep 23, 2024
pulisher
Sep 23, 2024

Barrow Hanley Mewhinney & Strauss LLC Purchases Shares of 898,419 Helios Technologies, Inc. (NASDAQ:HLIO) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Hancock Whitney Corp Buys 10,920 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

PHINIA Inc. (NYSE:PHIN) Shares Acquired by Long Road Investment Counsel LLC - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

King Luther Capital Management Corp Boosts Position in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

Texas Permanent School Fund Corp Has $1.39 Million Stock Holdings in PHINIA Inc. (NYSE:PHIN) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Thailand's new celebrity baby pygmy hippo, Moo Deng - The Business Standard

Sep 20, 2024
pulisher
Sep 18, 2024

Bokf Na Has $58,000 Stock Position in Haleon plc (NYSE:HLN) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

American Century Companies Inc. Raises Position in PHINIA Inc. (NYSE:PHIN) - Defense World

Sep 18, 2024

Phio Pharmaceuticals Corp Azioni (PHIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):